Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of preceding long-dwell solution on 3.86% glucose PET results in CAPD
NL-OMON26400Not yet recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of icodextrin and glucose in chronic kidney disease (CKD) and kidney failure (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: D/P creatinine. Planned start Oct 2009; status: not yet recruiting.
02
Drugs
icodextringlucose
03
Conditions
chronic kidney disease (CKD)kidney failure
Beyond the preview
Go deeper on NL-OMON26400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26400.